Similarly, tuning the affinity of CAR to EGFR (a TAA robustly expressed on multiple human cancers [16]) increases the ability of CAR-T cells to kill tumor cells rather than normal tissues with lower EGFR expression [17] (Fig. 2B). Here, EGFR is linked to neoplasm.